Industry News
Emerson and GE Healthcare collaborate on biopharma manufacturing
GE Healthcare's Life Sciences business and Emerson Process Management have announced a collaboration aimed at increasing productivity and improving efficiency in the production of biopharmaceuticals such as monoclonal antibodies and vaccines. [ + ]
CSIRO maintains European patent for shRNA gene silencing technology
CSIRO has successfully defended a key patent for RNA interference (RNAi) gene silencing technology after opposition in Europe. [ + ]
New chair of Innovation Australia appointed
Christopher Pyne has announced Bill Ferris AC as the new chair of Innovation Australia, where he will perform a key role in the Australian Government's new focus on innovation. [ + ]
Mutant MYC inhibited by Phylogica
Phylogica has announced the inhibition of the mutant gene MYC — which many cancers depend on for their survival — in an animal model. [ + ]
Gender equity introduced to Viertel Foundation fellowships
The Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowships are being awarded to one male and one female outstanding mid-career scientist for the first time, in a move which will see gender equity embedded in the awards from now on. [ + ]
Australia's biggest ageing study just got better
Enhancements to the Sax Institute's 45 and Up Study will help drive research into the genetic causes of various diseases, as well as to build predictive models on the risk of disease. [ + ]
Balnaves Foundation funds two more child cancer researchers
The Balnaves Foundation has awarded two Children's Cancer Institute Australia researchers $100,000 each to explore uncharted territory in childhood cancer. [ + ]
Date set for Merck's Sigma-Aldrich acquisition
Merck is set to complete its US$17 billion acquisition of Sigma-Aldrich, having received final approval from the European Commission (EC). [ + ]
Two drug discovery initiatives for UniQuest
The commercialisation company of The University of Queensland, UniQuest, will be part of two separate drug discovery initiatives. [ + ]
Monash dominates Victorian Young Tall Poppy awards
The Australian Institute of Policy and Science has announced the 2015 Victorian Young Tall Poppy Science Awards, celebrating the best and brightest young achievers in the state. [ + ]
Science Gallery Melbourne gets a director
Rose Hiscock has been announced as the inaugural director of Science Gallery Melbourne, a venue for science and art collaboration planned for the heart of Melbourne's new innovation precinct. [ + ]
Invion's share purchase plan and asthma trial
Invion has opened a share purchase plan (SPP), allowing eligible shareholders to purchase up to $15,000 worth of shares at a discount and without any brokerage or transaction costs. [ + ]
A heart failure drug that reduces scar tissue
Drug development company Armaron Bio has begun its Phase II clinical trial for NP202, its lead candidate drug for heart failure. [ + ]
$630 million for health and medical research projects
Minister for Health Sussan Ley has announced $630 million to support Australia's researchers in their search to find the next prevention of disease or cure. [ + ]
New nanoscale biophotonics research node
The ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) has officially launched its new research node at Macquarie University. [ + ]
